Postinjection delirium/sedation syndrome in a transgender man undergoing hormone therapy

Postinjection delirium/sedation syndrome in a transgender man undergoing hormone therapy

Background: Long-acting injectable medications have become an important tool in the treatment of schizophrenia and schizoaffective disorder due to the high rates of medication nonadherence. Olanzapine long-acting injection (OLAI) is a useful therapeutic option for patients who have good tolerability...

Full description

Bibliographic Details
Main Authors: Joshua Gerving, PharmD, BCPS, BCPP, Heather Walser, PharmD, BCPP, Anne C. Kelly, MD
Format: Article
Language:English
Published: American Association of Psychiatric Pharmacists 2023-08-01
Series:Mental Health Clinician
Subjects:
antipsychotic agents
drug-related side effects and adverse reactions
schizophrenia
olanzapine
transgender
hormonal therapy
testosterone
Online Access:https://theijpt.org/doi/pdf/10.9740/mhc.2022.08.263

Internet

https://theijpt.org/doi/pdf/10.9740/mhc.2022.08.263

Similar Items